Alexion Pharmaceuticals, Inc.
Registered Principal Details
Business Or Interest:
Pharmaceutical Research, Development, and Manufacturing.
Lobbying Interests:
Access to genetic testing in Medicaid. State government relations representation before the Wisconsin State Legislature and State agencies on matters related to prescription drugs, health care, health insurance, Medicaid and pharmacy issues.
CEO Name:
Marc Dunoyer
Pharmaceutical Research, Development, and Manufacturing.
Lobbying Interests:
Access to genetic testing in Medicaid. State government relations representation before the Wisconsin State Legislature and State agencies on matters related to prescription drugs, health care, health insurance, Medicaid and pharmacy issues.
CEO Name:
Marc Dunoyer
Contact
MO
Matthew O'Donnell
121 Seaport Boulevard
Boston, MA 02210
(475) 267-8837
compliance_WI_alexion@multistate.us
https://alexion.com/
121 Seaport Boulevard
Boston, MA 02210
(475) 267-8837
compliance_WI_alexion@multistate.us
https://alexion.com/
Authorized Lobbyists
| Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
|---|---|---|---|
| Brian Rosen | Exclusive Duties No | Authorized On 1/16/2025 | Withdrawn On N/A |
| Jordan Lamb | Exclusive Duties Yes | Authorized On 1/16/2025 | Withdrawn On N/A |
Lobbying Interests
Topics Not Yet Assigned A Bill Or Rule Number
Development, drafting or introduction of a proposal relating to
Rare Diseases
Rare Diseases
Action Intended To Affect
Both Legislative matter and rule
Notification Date
1/29/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Both Legislative matter and rule
Notification Date
1/29/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
Regulation of Prescription Drugs
Regulation of Prescription Drugs
Action Intended To Affect
Both Legislative matter and rule
Notification Date
1/16/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Both Legislative matter and rule
Notification Date
1/16/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
2025-2027 Biennial Budget Bill
2025-2027 Biennial Budget Bill
Action Intended To Affect
Legislative matter
Notification Date
1/16/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Legislative matter
Notification Date
1/16/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Total Lobbying Effort
No certified reports found.
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
No legislative bills/resolutions found.
Budget Bill Subjects
No budget bill subjects found.
Administrative Rulemaking Proceedings
No administrative rulemaking proceedings found.
Topics Not Yet Assigned A Bill Or Rule Number
No topics found.
Minor Efforts
No minor efforts found.
Other Matters
No other matters found.